(Health-NewsWire.Net, September 12, 2018 ) The key players in the next-generation sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).
Click Here for Free Sample Papers at http://www.rnrmarketresearch.com/contacts/request-sample?rname=507635 . 215 Pages 13 Profiling 96 Tables 35 Figures
The high growth in this segment can be attributed to the development of advanced NGS-based diagnostic solutions and growing number of agreements between companies and hospitals for developing advanced tests and products catering to the specific needs of hospitals and clinics.
Premium Insights 1 Next-Generation Sequencing (NGS): Market Overview 2 NGS Market, By Product & Service, 2018 vs 2024 3 NGS Market, By Technology, 2018 vs 2024 (USD Million) 4 NGS Market, By Application, 2018 vs 2024 (USD Million) 5 NGS Market, By End User and Region, 2018
Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel the growth of this market.
Stakeholders 1 NGS equipment manufacturers, vendors, and distributors 2 NGS sequencing service companies 3 NGS bioinformatics/data analysis companies 4 Research laboratories and academic institutes 5 Venture capitalists and other government funding organizations 6 Research and consulting firms 7 Healthcare institutions (hospitals and diagnostic clinics) 8 Pharmaceutical and biotechnology companies 9 Contract manufacturing organizations (CMOs) 10 Contract research organizations (CROs)
Click Now for More Details on Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024 report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=507635 .
This report studies the next-generation sequencing market based on product & service, technology, application, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
Breakdown of supply-side primary interviews: by company type, designation, and region: By Company Type: Tier 1 - 40%, Tier 2 - 25%, and Tier 3 - 36% By Designation: C-level - 43%, Director-level - 22%, and Others - 35% By Region: North America - 37%, Europe - 12%, APAC - 41%, and RoW -10%
Purchase this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=507635 .
ReportsnReports
Mr. Hrishikesh
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com
|